Hospital
DLP Swain County Hospital, LLC
DLP Swain County Hospital, LLC was paid $3.94M by Medicaid between Jan 2018 and Dec 2024, across 72 billing codes. Its largest line is 99283, emergency room visit (moderate) — 37% of everything it billed.
33Billing provider infoDLP SWAIN COUNTY HOSPITAL, LLC
BRYSON CITY, NC 28713
BRYSON CITY, NC 28713
33aNPI1689780249assigned 08/23/2006
33bProvider typeCritical Access Hospital
28Total paid$3.94M
24GClaims63,945
24DCodes billed72
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in North Carolina
Rank by total paid#8 of 25
Median peer was paid$1.32M
This provider vs. median3.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,483 | $609K | |
| 2019 | 12,688 | $509K | |
| 2020 | 6,651 | $256K | |
| 2021 | 7,850 | $472K | |
| 2022 | 7,903 | $705K | |
| 2023 | 8,020 | $699K | |
| 2024incomplete | 7,350 | $689K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 37% | 9,678 | 8,138 | $1.44M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 24% | 4,763 | 3,881 | $964K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 12% | 11,786 | 9,603 | $458K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.3% | 1,482 | 1,222 | $364K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.3% | 3,174 | 2,596 | $168K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 4,925 | 2,470 | $71K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.4% | 2,260 | 1,844 | $57K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 554 | 504 | $49K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.1% | 169 | 145 | $43K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,784 | 1,522 | $33K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 462 | 404 | $29K |
| 80053 | Comprehensive metabolic panel | <1% | 3,123 | 2,608 | $22K |
60 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,224 | $22K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 122 | $20K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,932 | $19K |
| 87070 | <1% | 1,258 | $15K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 431 | $15K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 618 | $13K |
| 71045 | Radiologic examination, chest; single view | <1% | 180 | $12K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 189 | $11K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 873 | $11K |
| 99173 | <1% | 957 | $10K | |
| 92552 | <1% | 790 | $10K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 358 | $10K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,710 | $9K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 863 | $7K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 575 | $7K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 470 | $7K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 58 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 112 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,446 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 59 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 99 | $3K |
| 80306 | <1% | 251 | $2K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 35 | $2K |
| 87807 | <1% | 120 | $2K | |
| 80061 | Lipid panel | <1% | 102 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 78 | $1K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 25 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 48 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 115 | $1K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 72 | $1K |
| 81001 | <1% | 428 | $1K | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 48 | $924.86 |
| 90686 | <1% | 508 | $877.72 | |
| 87430 | <1% | 58 | $671.16 | |
| 90474 | <1% | 57 | $529.53 | |
| 90698 | <1% | 218 | $445.20 | |
| 85730 | <1% | 111 | $443.91 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 36 | $382.87 |
| 84484 | <1% | 49 | $318.76 | |
| 85610 | <1% | 116 | $300.65 | |
| 82553 | <1% | 46 | $273.41 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 62 | $272.37 |
| 83880 | <1% | 12 | $253.80 | |
| 84439 | <1% | 15 | $217.63 | |
| 82550 | <1% | 47 | $170.31 | |
| 85018 | <1% | 1,288 | $121.15 | |
| 83655 | <1% | 16 | $105.56 | |
| 84703 | <1% | 13 | $93.60 | |
| 87088 | <1% | 18 | $85.27 | |
| 86140 | <1% | 19 | $77.40 | |
| 83735 | <1% | 16 | $66.80 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 20 | $52.41 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 16 | $30.46 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 15 | $30.44 |
| 81003 | <1% | 14 | $16.80 | |
| 90680 | 0% | 57 | $0.00 | |
| 90744 | 0% | 12 | $0.00 | |
| 90670 | 0% | 254 | $0.00 | |
| 90633 | 0% | 29 | $0.00 | |
| 90685 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.